- Home
- GVH vs ENLV Comparison
GVH vs ENLV Comparison
Compare GVH & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GVH
- ENLV
- Stock Information
- Founded
- GVH 2016
- ENLV 2005
- Country
- GVH Australia
- ENLV Israel
- Employees
- GVH N/A
- ENLV N/A
- Industry
- GVH
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- GVH
- ENLV Health Care
- Exchange
- GVH Nasdaq
- ENLV Nasdaq
- Market Cap
- GVH 21.3M
- ENLV 23.7M
- IPO Year
- GVH 2023
- ENLV 1995
- Fundamental
- Price
- GVH $0.08
- ENLV $1.13
- Analyst Decision
- GVH
- ENLV Strong Buy
- Analyst Count
- GVH 0
- ENLV 2
- Target Price
- GVH N/A
- ENLV $10.00
- AVG Volume (30 Days)
- GVH 84.6M
- ENLV 101.3K
- Earning Date
- GVH 02-12-2025
- ENLV 08-29-2025
- Dividend Yield
- GVH N/A
- ENLV N/A
- EPS Growth
- GVH 12.04
- ENLV N/A
- EPS
- GVH 0.09
- ENLV N/A
- Revenue
- GVH $16,540,178.00
- ENLV N/A
- Revenue This Year
- GVH N/A
- ENLV N/A
- Revenue Next Year
- GVH N/A
- ENLV N/A
- P/E Ratio
- GVH $0.82
- ENLV N/A
- Revenue Growth
- GVH N/A
- ENLV N/A
- 52 Week Low
- GVH $0.06
- ENLV $0.81
- 52 Week High
- GVH $1.82
- ENLV $1.76
- Technical
- Relative Strength Index (RSI)
- GVH 21.56
- ENLV 62.52
- Support Level
- GVH $0.06
- ENLV $0.90
- Resistance Level
- GVH $0.10
- ENLV $1.30
- Average True Range (ATR)
- GVH 0.14
- ENLV 0.09
- MACD
- GVH -0.15
- ENLV 0.01
- Stochastic Oscillator
- GVH 0.81
- ENLV 70.00
About GVH Globavend Holdings Limited
Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.